Structure-Based Design of Novel Dihydroalkoxybenzyloxopyrimidine Derivatives as Potent Nonnucleoside Inhibitors of the Human Immunodeficiency Virus Reverse Transcriptase

Two highly potent dihydroalkoxybenzyloxopyrimidine (DABO) derivatives targeting the nonnucleoside inhibitor (NNI) binding site of human immunodeficiency virus (HIV) reverse transcriptase (RT) have been designed based on the structure of the NNI binding pocket and tested for anti-HIV activity. Our le...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Sudbeck, Elise A., Mao, Chen, Vig, Rakesh, Venkatachalam, T. K., Tuel-Ahlgren, Lisa, Uckun, Fatih M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC106026/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9835518/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.12.3225
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!